Site updated at Wednesday, 22 June 2016

Living with Dementia

Psychotic Symptoms

Acadia redesigns study on Parkinson’s psychosis drug

Acadia Pharmaceuticals Inc said it redesigned an ongoing late-stage study on its experimental anti-psychotic drug for Parkinson’s disease patients, and that it plans to conduct an identical study to win regulatory approval.

The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at… Acadia redesigns study on Parkinson’s psychosis drug   

Out of the shadows - Living with dementia

amyotrophic lateral sclerosis6 - journal of the american geriatrics society1 - coping strategies1 - gammagard1 - medium spiny neurons1 - carus1 - treatments for alzheimer's1 - developing alzheimers2 - thomas willis1 - stress2 - insomnia2 - memory problems3 - development of alzheimer's1 - parkinson's sufferer1 - substantial hippocampal atrophy1 - agitation2 - symptoms of dementia3 - gradual degeneration1 - prion disease1 - loss of neuronal connections1 - dsm iv3 - magnetic resonance spectroscopy1 - aricept1 - depressive pseudodementia1 - alzheimers gene1 - psychosis polyneurotica1 - cvd1 - dementia of the alzheimer type1 - amentia2 - brain disorder1 -